Health
Team researching how effector and killer T cells can be controlled to destroy cancer cells that resist treatment – Californianewstimes.com
From left: Xinying Zong, PhD. Yongqiang Feng, PhD; and Dr. Xiaolei Hao (all of St. Jude Immunology) are studying ways to control effector and killer T cells to…
From left: Xinying Zong, PhD. Yongqiang Feng, PhD; and Dr. Xiaolei Hao (all of St. Jude Immunology) are studying ways to control effector and killer T cells to destroy treatment-resistant cancer cells. Credits: St. Jude Children’s Research Hospital
Effector and killer T cells are a type of immune cell. Their job is to attack pathogens and cancer. These cells can also target normal cells that cause autoimmune diseases. However, when used properly, it can destroy cancer cells that resist treatment….
-
General22 hours agoDonald Trump’s initial 10 per cent tariff takes effect
-
General21 hours agoJaguar Land Rover in UK pauses shipments to US
-
General18 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General17 hours agoAustralian share market set to dive as threat of US recession grows